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C.P. Gibbons*Morriston Hospital, Swansea SA2 7NW, UKPrimary vascular access is usually achievable by a distal autogenous arterio-venous fistula (AVF). This article describes the
approach to vascular access planning, the usual surgical options and the factors affecting patency..
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Whilst many patients with end stage renal failure
obtain renal replacement therapy by peritoneal dialysis
or renal transplantation, almost all will require a period
of haemodialysis and most will be maintained on this
modality over a long period. To achieve successful and
reliable haemodialysis easy access to the circulation is
required which provides a blood flow through the
dialysis machine in excess of 2–300 ml/min. Tempor-
ary access is required for patients presenting acutely
with renal failure whilst awaiting placement and
maturation of a permanent access but in about two
thirds of patients the need for renal replacement
therapy can be anticipated, allowing permanent
vascular access to be created in advance.Temporary Access
In the 1960s haemodialysis was performed via external
arterio-venous shunts1 but these were uncomfortable
for the patient, had the potential for sudden dis-
connection with severe haemorrhage, and frequently
underwent thrombosis or infection.2 The autogenousenal Access and Transplantation — one of a series of
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great advantages for permanent access but Scribner
shunts continued to be used for emergency access. The
double lumen central venous catheter, introduced in
1980,4 rapidly superseded the Scribner shunt for
emergency access, providing reliable access with
good flows and could be maintained for weeks or
months, especially if a Dacron cuff was incorporated in
a subcutaneous tunnel to act as a barrier to infection.5
Despite modifications, central venous catheters have
proved unsuitable for long-term use, except in patients
with a short life expectancy or in whom other
opportunities for access have been exhausted, because
of their increased rates of bacteraemia, repeated
episodes of thrombosis and the risk of central venous
stenosis or thrombosis.6Permanent Vascular Access for HaemodialysisVascular access planning
† Permanent access is best provided by an auto-
genous arterio-venous fistula (AVF), although in
the absence of adequate superficial veins a pros-
thetic AV bridge graft may be used.7,8 In most
European series over 90% of patients receive an
autogenous AVF and it has been suggested that at
least 80% of prevalent patients should dialyse via
an autogenous fistula and 66% of new patients
should start dialysis with an AVF.9Eur J Vasc Endovasc Surg 31, 523–529 (2006)
doi:10.1016/j.ejvs.2005.10.006, available online at http://www.sciencedirect.com onved.
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of available sites, starting as distally as possible, to
allow the construction of a more proximal fistula in
the event of failure. The non-dominant arm is
preferred to allow tasks such as writing during
dialysis and self-needling if home dialysis is
anticipated.
† When access sites on the non-dominant arm are
unavailable, the dominant arm and, as a last resort,
the leg can be used.
† There is increasing evidence that preoperative
duplex scanning improves the selection of the
level of a fistula, reduces the failure rate10 and
increases the number of autogenous fistulae in
units with high prosthetic graft usage.11 It is
particularly helpful in obese patients where pre-
operative scanning ensures a similar rate of
formation of a functioning AV fistula.12Fig. 1. The radiocephalic fistula at the wrist. (a) Completed
fistula before skin closure. (b) Needle positions for dialysis.The radiocephalic AV fistula
For long-term access the radiocephalic AVF at the
wrist has proved the gold standard over many years.3
The operation is straightforward and is easily accom-
plished under local anaesthetic. The cephalic vein is
mobilised to reach the radial artery, which lies just
medial to the brachioradialis tendon at the wrist
(Fig. 1). In most patients it provides an excellent blood
flow along the cephalic vein, which usually lies
superficially over a long length of the forearm. This
allows easy cannulation by two widely separated
needles so that recirculation is rarely a problem, except
in failing fistulae, and gives efficient dialysis as
measured by Kt/V. In obese patients where the
cephalic vein is located too deeply for easy cannula-
tion it can be transposed into a more superficial
position.13 The results are generally good with a 15%
primary failure rate14, 1-year patencies of 70–85% and
5-year patency of about 50%.15,16 Complications such
as needle site infections or haemorrhage are rare. In
the long term, venous aneurysms are common but
rupture is rare so that most can safely be observed.
Occasionally, sudden enlargement occurs, but threa-
tened haemorrhage may be averted by timely fistula
ligation or revision. Steal syndromes are similarly
uncommon, occurring in !2%.17
The initial report described a side-to-side anasto-
mosis3 but an end-to-side anastomosis between the
vein and artery is now usually preferred as mobilis-
ation of the vein is easier. The distal flow into the hand
from a side-to-side fistula rarely has any clinical
significance and occasionally causes troublesomeEur J Vasc Endovasc Surg Vol 31, May 2006venous hypertension with ulceration of the thumb.
The direction of flow in the distal radial artery is
reversed in about three quarters of patients with a
variable contribution of the blood flow from the
palmar arch.18 This causes a reduced blood pressure
in the thumb in most cases but this is rarely significant
clinically19 but if the inflow to the arch via the ulnar
artery is deficient a steal syndrome may result, with
ischaemia of the thumb and index finger. An end-to-
end anastomosis between the proximal radial artery
and the cephalic vein with ligation of the distal radial
artery avoids this and is performed routinely in some
units.20 Nevertheless the end-to-side configuration
remains more popular as fistula thrombosis usually
leaves the radial artery in continuity to contribute to
perfusion of the hand and the rare cases of steal
usually respond to distal radial artery ligation beyond
the fistula.19,21
Fig. 2. The snuffbox AV fistula. (a) Completed fistula before
skin closure. (b) Needle positions for dialysis.
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A radiocephalic AVF in the anatomical snuffbox (Fig. 2)
is an excellent option in most patients and is the
author’s preferred first access.22 The radial artery lies
deep to the extensor retinaculum as it passes across the
snuffbox, which it enters beneath the tendons of
extensor pollicis brevis and abductor pollicis longus
and exits between the heads of the first dorsal
interosseus muscle. Whilst the vessels are slightly
smaller and the artery is deeper with more branches
to divide formobilisation than at the wrist, the cephalic
vein lies immediately superficial to the artery and
requires little mobilisation. This fistula gives an extra
few centimetres of vein for needle insertion and
following thrombosis a wrist fistula can be constructed
in about 45%ofpatients. Inwomen theveins areusually
smaller and the patency of AVFs is poorer than in men,
so they more often require a more proximal fistula.Forearm radiocephalic AV fistulae
The popularity of the distal cephalic vein for intrave-
nous infusion in hospitals often leads to its thrombosis
or phlebitis. Where thrombosis remains distal and the
radial artery is adequate amoreproximal radiocephalic
AVF can be performed in the forearm. Here the radial
artery lies deep to brachioradialis, which must be
partially divided to give adequate exposure.Fig. 3. The ulnobasilic AV fistula. (a) Completed fistula
before skin closure. (b) Needle positions for dialysis.The ulnobasilic AV fistula
The basilic vein is usually of good calibre and is rarely
used for intravenous cannulation leaving it availablefor fistula creation in most patients.23,24 The ulnar
artery is found between the tendons of flexor carpi
ulnaris and flexor digitorum superficialis at the wrist
where it lies medial to the ulnar nerve on flexor
digitorum profundus and the basilic vein can be easily
mobilised for anastomosis to it (Fig. 3). However, it is
less popular because cannulation of the basilic vein isEur J Vasc Endovasc Surg Vol 31, May 2006
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pressure on the basilic vein when the forearm rests on
a table or the arm of a chair.Other autogenous forearm AV fistulae
Whereas options for primary access usually depend
upon venous availability, elderly patients with renal
failure are frequently subject to atheromatous or calcific
arterial disease affecting the upper limb, which may
limit options for fistula formation. In some cases, aFig. 4. The brachiocephalic AV fistula. (a) Aneurysmal
fistula. (b) Needle positions for dialysis.
Eur J Vasc Endovasc Surg Vol 31, May 2006patent basilic vein may be mobilised subcutaneously
across the anterior surface of the forearm to form a
radiobasilic fistula and conversely an ulnocephalic
fistula may occasionally be the most distal option.Brachial AV fistulae
The considerable variability of venous anatomy in the
antecubital fossa allows a variety of possible configur-
ations for brachial fistulae (Fig. 4). An end-to-side
anastomosis of the median cephalic vein brachioce-
phalic AV fistula in the antecubital fossa gives
excellent access to the circulation via needles in the
upper arm cephalic vein. Reported patencies are
excellent, and higher blood flows result but the
incidence of steal is greater.25 Higher flows can be
achieved when both the median cephalic and median
basilic (median cubital) veins are included in the
outflow and this may accomplish maturation of the
basilic vein for a possible later basilic vein trans-
position fistula the potential for steal is increased. The
deep perforating vein can also be anastomosed end to
side to the brachial artery,26 which allows flow up both
the cephalic and basilic veins but the smaller
anastomosis may reduce the risk of steal without
affecting patency.27 Distal flow into a patent cephalic
vein can sometimes be achieved by valve disruption.Other options
Whilst in the vast majority of cases an upper limb
autogenous fistula is possible there are a few patients
in whom no suitable subcutaneous veins exist and
primary access must be accomplished by a prosthetic
graft, basilic vein transposition or even a lower limb
fistula. These will be described in subsequent articles.Factors Affecting Fistula PatencyVessel size
Small arteries and veins have higher initial failure
rates, more frequent failure to mature and poorer long-
term patency.28 It has been suggested that a cut-off of
2 mm for both the arterial and venous diameters
should be used.Fistula flow rates
The flow rate AV fistulae the day after surgery
correlates inversely with the risk of thrombosis
Primary Vascular Access 527although intraoperative flow rates are less reliable.28
The hyperaemic response of brachial artery blood flow
is a strong predictor of access patency and maturation,
presumably by detecting proximal arterial stenoses.29Access surveillance
The use of postoperative surveillance and pre-emptive
repair of detected defects has been shown to improve
access survival in a randomised controlled trial.30Prior temporary access
Patients presenting acutely with renal failure have
poorer AVF patency, which may be linked to the need
for temporary access via a central venous catheter.31Anastomotic method
Anastomosis using non-penetrating vascular clips,
which give an interrupted anastomosis with excellent
endothelial apposition and less bleeding, are quicker
and may have improved patencies.32,33Access position
More proximal AV fistulae have improved blood
flow34 and patency35 but leave fewer options for
access in the event of failure.Early cannulation
This is not a risk factor for fistula thrombosis.36Prosthetic AV grafts
Prosthetic AV grafts have poorer primary patency,
require more revisions and have higher infection rates
than autogenous AVFs.37–39 However, their patency
can be improved by using a wider diameter graft40 or
adding a vein cuff to the venous anastomosis.41Gender
The patency of distal forearm, wrist or snuffbox AVFs
is poorer in women than in men.22,31,35,42 Since, this
seems to apply also to more proximal AVFs it may be
unrelated to the larger vessels of men and may have a
hormonal basis.Diabetes
There is conflicting evidence as to whether diabetes is
an adverse factor for fistula patency with some authors
suggesting that flow rates34 and patency are poorer35
whereas others have found no effect.22,43,44Age
Increasing age has no effect on fistula patency.22,45Obesity
It is more difficult to create a suitable AV fistula in
obese patients because the deeper veins are more
difficult to cannulate but this does not affect patency.34Smoking
Smokers may have poorer fistula survival.46Drugs
Antiplatelet agents such as aspirin and dipyridamole
prolong fistula survival and are used routinely47–49
although a combination of aspirin and clopidogrel
increased haemorrhagic complications without influen-
cing patency in prosthetic AV grafts.50 Anticoagulation
with warfarin reduces AVF thrombosis in patients with
hypercoagulable states51 but routine use is best avoided
because of the risk of haemorrhage.52 Surprisingly,
warfarin was associated with poorer patency in the
DOPPS study but thismay reflect its use in patientswith
a history of fistula thrombosis or known thrombotic
disorders.49 Calcium channel blockers are associated
with improved primary patency.49 ACE inhibitors were
found to have no effect on primary access patency in one
study53 but were associated with improved secondary
patency in the DOPPS study.49 Fish oil reduced the
primary rateofAVfistula thrombosis inone randomised
trial.54 Erythropoeitin does not reduce55 and, surpris-
ingly, may improve patency, at least of AV grafts.56Thrombotic tendencies and vasculitis
Increased fibrinogen predisposes to access thrombosis
and vasculitis is a strong predictor of access failure.57Surgical expertise
There can be little doubt that experienced surgeons
with adequate training have good outcomes35 butEur J Vasc Endovasc Surg Vol 31, May 2006
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results.58Management of the AV Fistula
It is essential to avoid unnecessary venepuncture and
intravenous infusions in forearm and antecubital veins
(especially the cephalic) both before and after AVF
formation. External compression by tight clothing,
bracelets or wristwatches should also be avoided.
Cannulation is usually delayed for 6 weeks to allow
maturation and should be performed by experienced
nursing staff with strict asepsis. There are various
needling possible strategies but area puncture is
usually best for autogenous fistulae as it results in
localised venous dilatation at preferred sites, which
facilitates subsequent cannulation.59 There is now
good evidence that fistula surveillance by flow rate
monitoring or by duplex scanning improves outcome.
Thrombosis of autogenous fistulae or failure to mature
is usually best treated by surgical revision or
construction of a new AV fistula at a higher level
although thrombolysis and angioplasty may have a
place.Conclusions
† Primary access is best provided by a distal
autogenous AV fistula in the nondominant arm.
† For proximal AV fistulae may be required in
patients with poor veins.
† Preoperative duplex scanning facilitates planning.
† Patency is improved by antiplatelet agents, fish oil
and calcium channel blockers.
† Patency is worse in patients who present as an
emergency, in women, smokers and in the presence
of athrombotic tendency or vasculitis.References
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